Incyte Genomics Inc Share Price
NASDAQ: INCYHealthcare
Live Incyte Genomics Inc Share Price Chart
O H L
Incyte Genomics Inc Performance Overview
Days Range
▼
$125.24Low
$126.18High
Markets Today
| Previous Close | $124.75 |
|---|---|
| Open | $125.44 |
| Volume | 205,630 |
| Day's Range | $125.24 - $126.18 |
| 52W Range | $81.09 - $132.60 |
| Market Cap | $24.68 B |
Historical Performance
| 1M Returns | +1.01 |
|---|---|
| 3M Returns | +26.02 |
| 6M Returns | +32.40 |
| 1Y Returns | +47.11 |
| 5Y Returns | +64.17 |
| 10Y Returns | +49.38 |
Incyte Genomics Inc Fundamentals
| Market Cap | $24.68 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 15.51 |
| PEG Ratio | N/A |
| Revenue | $5.14 B |
| ROE TTM | 0.30 |
| EPS TTM | $7.85 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.86 |
| EBITDA | $1.44 B |
| Profit Margin | 25.03 |
| Market Cap | $24.68 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 15.51 |
| PEG Ratio | N/A |
| Revenue | $5.14 B |
| ROE TTM | 0.30 |
| EPS TTM | $7.85 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.86 |
| EBITDA | $1.44 B |
| Profit Margin | 25.03 |
Incyte Genomics Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.05 B | $1.22 B | $1.37 B | $1.51 B | $1.27 B | $1.67 B |
| Gross Profit + | $979.71 M | $1.14 B | $1.27 B | $1.39 B | $1.17 B | $1.57 B |
| Operating Income | $205.17 M | $530.31 M | $443.52 M | $335.86 M | $301.12 M | $697.90 M |
| EBITDA | $227.53 M | $310.98 M | $455.34 M | $413.99 M | $348.13 M | $724.37 M |
| Interest Expense | -$660.00 K | -$594.00 K | -$592.00 K | -$582.00 K | -$569.00 K | -$582.00 K |
| Depreciation | $22.36 M | -$219.33 M | $11.82 M | $78.13 M | $47.02 M | $26.48 M |
| Income Before Tax | $234.19 M | $558.01 M | $482.31 M | $389.94 M | $343.60 M | $751.51 M |
| Income Tax Expense | $75.99 M | $153.01 M | $58.14 M | $90.66 M | $40.27 M | $165.91 M |
| Net Income + | $158.20 M | $405.00 M | $424.17 M | $299.28 M | $303.33 M | $585.61 M |
| Net Profit Margin | 15.03% | 33.32% | 31.05% | 19.86% | 23.83% | 34.98% |
Incyte Genomics Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $193.00 K | $194.00 K | $196.00 K | $198.00 K | $200.00 K | $201.00 K |
| Reserve & Surplus | -$920.92 M | -$496.24 M | -$70.95 M | $239.23 M | $539.41 M | $1.12 B |
| Non-Current Liabilities | $361.51 M | $371.83 M | $340.43 M | $275.32 M | $226.62 M | $216.12 M |
| Current Liabilities | $1.72 B | $1.28 B | $1.34 B | $1.52 B | $1.49 B | $1.31 B |
| Total Liabilities | $2.08 B | $1.65 B | $1.68 B | $1.79 B | $1.72 B | $1.53 B |
| Fixed Assets | $872.97 M | $924.96 M | $918.05 M | $848.02 M | $830.33 M | $812.66 M |
| Current Assets | $3.51 B | $3.64 B | $4.28 B | $5.02 B | $5.48 B | $6.03 B |
| Total Assets | $5.75 B | $5.82 B | $6.33 B | $6.96 B | $7.34 B | $7.87 B |
Incyte Genomics Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $158.20 M | $405.00 M | $424.17 M | $299.28 M | $303.33 M | $585.61 M |
| Operating Cash Flow | $266.07 M | $44.74 M | $559.39 M | $543.30 M | $369.35 M | $507.66 M |
| Investing Cash Flow | $1.10 M | -$18.87 M | -$47.42 M | -$37.42 M | -$88.20 M | -$51.79 M |
| Financing Cash Flow | -$12.68 M | -$11.25 M | -$12.78 M | $137.74 M | $84.82 M | $65.46 M |
| Change in Cash | $253.94 M | $13.43 M | $500.04 M | $642.82 M | $363.28 M | $521.24 M |
Incyte Genomics Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $464.82B | 143.67% | 74.40 | 6.92% | 2.63% |
Incyte Genomics Inc Return Calculator
The Incyte Genomics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$16,617
Invested Amount$10,000
Est. Returns$6,617
About Incyte Genomics Inc
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
Popular Stocks
FAQs
What is the share price of Incyte Genomics Inc today?
Incyte Genomics Inc (INCY) share price as of September 17, 2026 is $126.27. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Incyte Genomics Inc?
Yes, Indian Investors can invest in the Incyte Genomics Inc (INCY) Share by opening an international trading account with Angel One.
How can I purchase Incyte Genomics Inc shares in India?
Purchasing Incyte Genomics Inc (INCY) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Incyte Genomics Inc (INCY) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Incyte Genomics Inc?
Yes, you can purchase fractional shares of Incyte Genomics Inc (INCY) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Incyte Genomics Inc?
The market capitalization of Incyte Genomics Inc on September 17, 2026, is $24.68 B.
In which sector Incyte Genomics Inc belongs?
Incyte Genomics Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Incyte Genomics Inc stocks?
In order to invest in Incyte Genomics Inc (INCY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
